Document Detail

Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense.
MedLine Citation:
PMID:  16014045     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Renin has been linked to the pathogenesis of some forms of hypertension, including cold-induced hypertension (CIH). Although several antihypertensive drugs that inhibit angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) type 1 (AT(1)) receptors are available, they are short-lasting and have side effects. Inhibition of renin [the first and rate-limiting step of the renin-angiotensin system (RAS)] would provide an inhibition of the entire RAS. Thus, we developed an antisense approach for specific inhibition of renin based on the genetic design. The objective of this study was to test our hypothesis that adenoviral delivery of renin antisense inhibits renin and attenuates CIH. METHODS: Recombinant adenoviruses carrying rat renin antisense (rAdv.RRA) and LacZ reporter gene (rAdv.LacZ) were constructed and used for in vivo gene transfer via intravenous injection. Four groups of rats were used (six rats/group). Blood pressure did not differ among the four groups during the control period at room temperature (25 degrees C). Two groups of rats received rAdv.RRA (2.5 x 10(9) pfu/rat, intravenously), while the other two groups received the same dose of rAdv.LacZ and served as controls. After gene delivery, one rAdv.LacZ-treated and one rAdv.RRA-treated group were exposed to cold (5 degrees C), while the remaining groups were kept at 25 degrees C. Blood pressure was monitored weekly during cold exposure. A 24-hour urine sample was collected during weeks 1, 3, and 5 for measuring urinary aldosterone excretion. At the end of week 5, all animals were killed and blood was collected for measurement of plasma renin activity (PRA), total plasma renin, plasma active renin, and plasma aldosterone. Vascular Ang II contents were measured in all rats. RESULTS: Blood pressure of the rAdv.LacZ-treated group rose significantly within 2 weeks of exposure to cold and reached 158.2 +/- 6.4 mm Hg by week 5. In contrast, blood pressure (117.1 +/- 5.3 mm Hg) of the cold-exposed group treated with rAdv.RRA did not increase until 5 weeks after exposure to cold. Thus, a single dose of rAdv.RRA prevented CIH for at least 5 weeks. rAdv.RRA abolished the cold-induced increases in PRA, total plasma renin, plasma active renin, vascular Ang II, and plasma and urine aldosterone, indicating effective inhibition of the entire RAS. CONCLUSION: rAdv.RRA effectively inhibited the entire RAS and produced prolonged attenuation of CIH. Antisense inhibition of renin may be a novel and ideal approach for long-term control of hypertension.
Xiuqing Wang; Zhongjie Sun; Robert Cade
Related Documents :
214795 - Reversal of renovascular hypertension by antibodies specific for angiotensin-converting...
10715 - Hypertension in end-stage renal disease. the relationship between blood pressure, plasm...
3319645 - Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold s...
674035 - Plasma renin activity in hypertensive and hypotensive turkeys.
6291915 - Plasma renin activity during infusion of epinephrine into the celiac and superior mesen...
23035145 - Maternal history of hypertension and blood pressure response to potassium intake: the g...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Kidney international     Volume:  68     ISSN:  0085-2538     ISO Abbreviation:  Kidney Int.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-07-14     Completed Date:  2005-10-13     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  680-7     Citation Subset:  IM    
Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32610, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenoviridae / genetics
Aldosterone / blood,  urine
Angiotensin II / blood
Blood Pressure
Cold Temperature / adverse effects*
DNA, Antisense / genetics
Gene Therapy / methods*
Hypertension / etiology,  prevention & control,  therapy*
Lac Operon
Rats, Sprague-Dawley
Renin / blood,  genetics*
Reg. No./Substance:
0/DNA, Antisense; 0/Galactosides; 0/Indoles; 11128-99-7/Angiotensin II; 52-39-1/Aldosterone; 7240-90-6/5-bromo-4-chloro-3-indolyl beta-galactoside; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women...
Next Document:  Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men.